PRO GENOME Limited having its registered office at Harchandrai House, 2nd floor,Above Axis Bank, Maharshi Krve Road,Marine Lines (E), MUmbai - 40000., www.nmprogenome.com, is proposing, subject to receipt of requisite approvals, market conditions and other considerations, an initial public offer of its equity shares in the near future and is in the process of filing a draft red herring prospectus with the Securities and Exchange Board of India. The equity shares have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any other applicable law of the United States and, unless so registered, may not be offered or sold within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable state securities laws. The equity shares may only be offered and sold (a) in the United States only to “qualified institutional buyers” (as defined in Rule 144A), in private transactions exempt from the registration requirements of the U.S. Securities Act, and (b) outside of the United States in offshore transactions as defined in and in compliance with Regulations and the applicable laws of the jurisdiction where any such offers and sales are made There will be no public offering in the United States.
General Terms & Conditions